Bio-Rad Laboratories BIO Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bio-Rad Laboratories's finance lease liabilities (total)?
- Bio-Rad Laboratories (BIO) reported finance lease liabilities (total) of $9.1M in Q1 2026.
- How has Bio-Rad Laboratories's finance lease liabilities (total) changed year-over-year?
- Bio-Rad Laboratories's finance lease liabilities (total) decreased by 4.2% year-over-year, from $9.5M to $9.1M.
- What is the long-term trend for Bio-Rad Laboratories's finance lease liabilities (total)?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's finance lease liabilities (total) has grown at a -4.4% compound annual growth rate (CAGR), from $11.5M to $9.2M.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.